MMP9 and ovarian carcinoma: Eight polymorphisms (MMP2 C-735T, MMP7 A-181G, MMP8 rs11225395, MMP9 rs6094237, MMP12 rs2276109, MMP20 rs2292730, MMP20 rs12278250, MMP20 rs9787933) were reported associated with ovarian cancer risk, while other polymorphisms could not be associated with ovarian cancer risk.